Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Hyperinsulinemia, glucose intolerance, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liver
Kazuaki Miyake, Wataru Ogawa, Michihiro Matsumoto, Takehiro Nakamura, Hiroshi Sakaue, Masato Kasuga
Kazuaki Miyake, Wataru Ogawa, Michihiro Matsumoto, Takehiro Nakamura, Hiroshi Sakaue, Masato Kasuga
View: Text | PDF
Article Metabolism

Hyperinsulinemia, glucose intolerance, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liver

  • Text
  • PDF
Abstract

Research Article

Authors

Kazuaki Miyake, Wataru Ogawa, Michihiro Matsumoto, Takehiro Nakamura, Hiroshi Sakaue, Masato Kasuga

×

Figure 4

Options: View larger image (or click on image) Download as PowerPoint
Time course of plasma insulin concentration in DNPI3K and LacZ mice, as ...
Time course of plasma insulin concentration in DNPI3K and LacZ mice, as well as the effects of Δp85 expression in the liver on responses to oral glucose intake. (a) Plasma insulin concentration was measured at the indicated times after adenovirus injection and food deprivation for 16 hours. (b–g) DNPI3K and LacZ mice were deprived of food for 16 hours and then loaded orally with glucose (2 g/kg) at 3 (b, c, and e–h) or 11 (d) days after the adenovirus injection. Blood glucose (b) and plasma insulin (c) concentrations were determined at the indicated times after glucose intake. Glycogen (e) and glucose 6-phosphate (f) contents, glycogen synthase activity (g), and phosphorylation of Akt (d, inset; and h) and of GSK3 (h) in the liver were assayed before (Pre) and 120 minutes after (Post) glucose load. Glycogen and glucose 6-phosphate (G-6-P) contents are expressed per gram of liver mass. Glycogen synthase activity is expressed as the ratio of values determined in the absence of glucose 6-phosphate to values determined in the presence of glucose 6-phosphate. Data are means ± SEM of values from three (a), ten (b), four (c, e and f), five (d) or six (g) mice, or are shown for two mice and representative of six mice (h) or shown for one mouse and representative of five mice (d, inset). *P < 0.05, **P < 0.01 compared with the corresponding value for LacZ mice.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts